Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Clinical practice guidelines: the need for greater transparency in formulating recommendations.

Moulds RF.

Med J Aust. 2011 Sep 19;195(6):324-5. No abstract available.

PMID:
21929489
2.

Antibiotic prophylaxis against infective endocarditis: time to rethink.

Moulds RF, Jeyasingham MS; Infective Endocarditis Prophylaxis Expert Group, Therapeutic Guidelines Limited.

Med J Aust. 2008 Sep 15;189(6):301-2. No abstract available.

PMID:
18803530
3.

A change of heart: the new infective endocarditis prophylaxis guidelines.

Daly CG, Currie BJ, Jeyasingham MS, Moulds RF, Smith JA, Strathmore NF, Street AC, Goss AN.

Aust Dent J. 2008 Sep;53(3):196-200; quiz 297. doi: 10.1111/j.1834-7819.2008.00049.x. Review.

4.

A Fijian perspective on providing a medical workforce.

Baravilala WR, Moulds RF.

Med J Aust. 2004 Dec 6-20;181(11-12):602. No abstract available.

PMID:
15588178
5.

Kava: herbal panacea or liver poison?

Moulds RF, Malani J.

Med J Aust. 2003 May 5;178(9):451-3.

PMID:
12720513
6.

Good prescribing: where to next?

Moulds RF.

Med J Aust. 2003 Mar 3;178(5):196-7. No abstract available.

PMID:
12603177
7.

Intern Prescribing for Common Clinical Conditions.

Pearson S, Smith AJ, Rolfe IE, Moulds RF, Shenfield GM.

Adv Health Sci Educ Theory Pract. 2000;5(2):141-150.

PMID:
12386470
8.

Preventable hospitalisation from underuse of drugs.

Carroll M, Dartnell J, Moulds RF.

Med J Aust. 1998 Aug 3;169(3):174. No abstract available.

PMID:
9734517
9.

New drugs, old drugs. Calcium antagonists.

Moulds RF.

Med J Aust. 1997 Nov 3;167(9):484-6. Review. No abstract available.

PMID:
9397064
10.
11.

From knowledge to action: improving drug prescribing.

Moulds RF.

Med J Aust. 1996 Sep 16;165(6):299-300. No abstract available.

PMID:
8862324
12.

Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs.

Dartnell JG, Anderson RP, Chohan V, Galbraith KJ, Lyon ME, Nestor PJ, Moulds RF.

Med J Aust. 1996 Jun 3;164(11):659-62.

PMID:
8657028
13.

Relationship between nifedipine sensitivity of aortae and blood pressure of stroke-prone spontaneously hypertensive rats.

Jiang GC, Iwanov V, Moulds RF.

Clin Exp Pharmacol Physiol. 1996 Mar;23(3):218-21.

PMID:
8934611
15.

Prescriber guidelines improve initiation of anticoagulation.

Dartnell JG, Allen B, McGrath KM, Moulds RF.

Med J Aust. 1995 Jan 16;162(2):70-3. Erratum in: Med J Aust 1995 Feb 20;162(4):197.

PMID:
7530800
16.

The difference in nifedipine sensitivity between hypertensive and normotensive rat aortae is dependent on age.

Jiang GC, Iwanov V, Moulds RF.

Clin Exp Pharmacol Physiol. 1995 Jan;22(1):17-20.

PMID:
7768030
17.

Pharmaceutical advertisements in Australian medical publications--have they improved?

Carandang ED, Moulds RF.

Med J Aust. 1994 Dec 5-19;161(11-12):671-2. No abstract available.

PMID:
7830633
18.

Assessment of general practitioners' management of hyperlipidaemia. A study using personal visits and a scenario-based questionnaire.

Lewis C, Howard D, Moulds RF, Mashford ML.

Aust Fam Physician. 1994 Oct;23(10):1934, 1937-41.

PMID:
7818393
19.

Remote testing for malignant hyperpyrexia.

Tonkin PA, Higham C, Moulds RF, Iwanov V, Russell WJ.

Anaesth Intensive Care. 1994 Aug;22(4):470-4. No abstract available.

PMID:
7978216
20.

Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention.

De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF.

Med J Aust. 1994 Apr 18;160(8):502-5.

PMID:
8170427
21.
22.

Sufentanil and alfentanil cause vasorelaxation by mechanisms independent of the endothelium.

Karasawa F, Iwanov V, Moulds RF.

Clin Exp Pharmacol Physiol. 1993 Nov;20(11):705-11.

PMID:
7905796
23.

Oral flucloxacillin in septicaemia.

Gobbo O, Street A, Bury RW, Moulds RF.

Med J Aust. 1992 Oct 19;157(8):575. No abstract available.

PMID:
1479999
24.

Promoting and advertising therapeutic goods. Trade Practices Commission report on self-regulation.

Moulds RF.

Med J Aust. 1992 Oct 19;157(8):513-4. No abstract available.

PMID:
1479969
25.

Rational therapeutics: the way ahead.

Moulds RF, Mashford ML.

Med J Aust. 1992 Jun 15;156(12):823-4. No abstract available.

PMID:
1603002
26.

Differences between rat and guinea pig aorta in postreceptor mechanisms of alpha 1-adrenoceptors.

Jenkin RA, Baldi MA, Iwanov V, Moulds RF.

J Cardiovasc Pharmacol. 1991 Oct;18(4):566-73.

PMID:
1724534
27.

Ponalrestat does not cause a protein binding interaction with warfarin in diabetic patients.

Moulds RF, Fullinfaw RO, Bury RW, Plehwe WE, Jacka N, McGrath KM, Martin FI.

Br J Clin Pharmacol. 1991 Jun;31(6):715-8.

28.

Anticonvulsants in pregnancy.

Kilpatrick CJ, Moulds RF.

Med J Aust. 1991 Feb 4;154(3):199-202. Review.

PMID:
1988794
29.
30.

A survey on the appropriateness of gentamicin assays.

Lee K, Allen B, Sinickas V, Hellyar A, Moulds RF.

Aust Clin Rev. 1991;11(4):150-3. No abstract available.

PMID:
1804075
31.

Lack of effect of granulocyte-macrophage colony stimulating factor on the rat aorta or human saphenous vein.

Watabe T, Moulds RF.

Clin Exp Pharmacol Physiol. 1990 Nov;17(11):799-803.

PMID:
2078907
32.
33.

Alpha adrenoceptor activation and postreceptor contractile mechanisms in the human digital artery.

Stevens MJ, Moulds RF.

J Pharmacol Exp Ther. 1990 Apr;253(1):375-80.

PMID:
2158549
34.

Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.

Johnson GJ, Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF.

Br J Clin Pharmacol. 1989 Jun;27(6):843-9.

35.

Drug advertising.

Moulds RF, Wing LM.

Med J Aust. 1989 Apr 3;150(7):410-1. No abstract available.

PMID:
2716670
36.
37.

Changing antibiotic prescribing by educational marketing.

Landgren FT, Harvey KJ, Mashford ML, Moulds RF, Guthrie B, Hemming M.

Med J Aust. 1988 Dec 5-19;149(11-12):595-9.

PMID:
3200183
38.

Herbal preparations--to regulate or not to regulate?

Moulds RF, McNeil JJ.

Med J Aust. 1988 Dec 5-19;149(11-12):572-4. No abstract available.

PMID:
3200177
39.

Analgesic guidelines. Part II.

Moulds RF.

Aust Nurses J. 1988 Nov;18(5):29-30. No abstract available.

PMID:
3214364
40.

Analgesic guidelines. Part I.

Moulds RF.

Aust Nurses J. 1988 Oct;18(4):28-9. No abstract available.

PMID:
3196233
41.

Plasma concentrations of unbound valproate and the management of epilepsy.

Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF.

Aust N Z J Med. 1987 Dec;17(6):574-9.

PMID:
3128970
42.

Human vascular alpha-adrenoceptors: the relevance of subtypes.

Moulds RF, Stevens MJ, Jenkin RA.

Clin Exp Pharmacol Physiol. 1987 May;14(5):379-84.

PMID:
2824101
43.

Strokes and hypertension--the effect of treatment.

Moulds RF.

Med J Aust. 1987 Apr 20;146(8):406-7. No abstract available.

PMID:
3614049
44.

Liquid chromatographic screening of diuretics in urine.

Fullinfaw RO, Bury RW, Moulds RF.

J Chromatogr. 1987 Apr 10;415(2):347-56.

PMID:
3584373
45.

Elimination of enoxacin in renal disease.

Bury RW, Becker GJ, Kincaid-Smith PS, Moulds RF, Whitworth JA.

Clin Pharmacol Ther. 1987 Apr;41(4):434-8.

PMID:
3470166
46.

Problems with herbal medicines.

Bury RW, Fullinfaw RO, Barraclough D, Muirden KD, Moulds RF, Anghie T.

Med J Aust. 1987 Mar 16;146(6):324-5. No abstract available.

PMID:
3821641
47.

A kinetic study of sulindac in the elderly.

Bayley N, Warne RW, Moulds RF, Bury RW.

Aust N Z J Med. 1987 Feb;17(1):39-42.

PMID:
3476045
48.

Changes in clearance of sodium valproate with changes in dose.

Kilpatrick CJ, Bury RW, Fullinfaw RO, Moulds RF.

Clin Exp Neurol. 1987;24:97-103.

PMID:
3151881
49.

An assessment of the usage of the plasma theophylline assay service in a teaching hospital.

Stewart RA, Johnson GJ, Bury RW, Moulds RF.

Med J Aust. 1986 Dec 1-15;145(11-12):605-6.

PMID:
3796370
50.

Drug advertising.

Moulds RF, Bochner F, Wing LM.

Med J Aust. 1986 Aug 4-18;145(3-4):178-9. No abstract available.

PMID:
3736489

Supplemental Content

Loading ...
Support Center